Meeting
2022 ASCO Annual Meeting
Double jeopardy? A closer look at cancer histories of individuals with multiple germline pathogenic variants.
Authors
Carolyn Horton
Ambry Genetics, Aliso Viejo, CA
Carolyn Horton , Min-Tzu Lo , Amal Yussuf , Colin Young , Cassidy Carraway , Nihat Bugra Agaoglu , Brittany L. Bychkovsky , Huma Q. Rana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10514)
DOI
10.1200/JCO.2022.40.16_suppl.10514
Abstract #
10514
Poster Bd #
393
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Spectrum of germline pathogenic variants among patients with cancer in Mexico.
First Author: Jose Luis Rodriguez Olivares
Poster
2022 ASCO Genitourinary Cancers Symposium
Hereditary cancer risk assessment in the community urology practice setting.
First Author: Neal D. Shore
First Author: Krystal Brown
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian